characterized immune cell subsets in the peripheral blood of melanoma patients, observing a reduction in peripheral T cells alongside an increase in tumor‐infiltrating CD8+ T cells in responders to ICIs.[135] Oliveira et al. The gene discussed is CD8A; the disease is melanoma.